SLN:NASDAQ
Silence Therapeutics PLC - ADR
19,73 $
arrow_upward
+0,05%(+0,010) 1D
6 նոյ, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SLN...
Open
19,75 $
High
19,77 $
Low
19,72 $
Mkt. cap
1,22 մլրդ
Avg. vol.
4,28 մլն
Volume
0,00
52-wk high
19,86 $
52-wk low
4,19 $
EPS
-1,45 $
Beta
1,34
Shares outstanding
60,21 մլն
No. of employees
88
Open
19,75 $
High
19,77 $
Low
19,72 $
Mkt. cap
1,22 մլրդ
Avg. vol.
4,28 մլն
Volume
0,00
52-wk high
19,86 $
52-wk low
4,19 $
EPS
-1,45 $
Beta
1,34
Shares outstanding
60,21 մլն
No. of employees
88
News stories
From web sources and news partners
Yahoo Finance
·
29 րոպե առաջ
Fox-Roku’s $22B Deal, A New Nasdaq Biotech And A $25B Chemicals Tie-Up: Deals Investors Are Watching
Benzinga
·
38 րոպե առաջ
History Suggests Last Week's Selloff Was a Buying Opportunity - State Street SPDR S&P 500 ETF Trust (ARCA
WTNH.com
·
2 ժամ առաջ
Asian markets bounce back after a recovery for AI stocks on Wall Street
Seeking Alpha
·
2 ժամ առաջ
Don't Sell After One Bad Day: Wait For A Rules-Based Timer To Turn Defensive (NYSEARCA:SPY)
Profile
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
About Silence Therapeutics PLC - ADR
CEOCraig A Tooman
Employees88
Founded1994
Headquarters-
SectorHealth Care
Industry-
Websitesilence-therapeutics.com